在Pembrolizumab诱导的自身免疫血液溶解性贫血后成功的Dostarlimab挑战:一个病例报告
Zaid Khamis1, Kai Wang1, Mohammad Aldalahmeh1
1Department of Internal Medicine Northwell Health/Staten Island University Hospital New York New York USA.
Clinical case reports
|August 20, 2025
概括
免疫检查点抑制剂 (ICI) 可能导致自身免疫解血性贫血 (AIHA). 这一案例显示,在AIHA解决后, 通过另一种ICI重新挑战成功, 为癌症患者提供了希望.
科学领域:
- 癌症学
- 免疫学
- 血液学
背景情况:
- 免疫检查点抑制剂 (ICI) 改变了癌症治疗,但可能导致严重的免疫相关不良事件 (irAEs).
- 药物诱导的自身免疫溶血性贫血 (AIHA) 是一种严重的irAE,可能需要停止ICI治疗.
- 在严重的血质IRA后,重新治疗ICI患者的安全性尚不清楚.
研究的目的:
- 在布罗利祖马布诱导的AIHA后,通过另一种ICI成功重试的案例.
- 探索持续免疫疗法的可行性,在患者出现严重的IRA.
主要方法:
- 一个66岁的女性患有子宫内膜癌的病例报告.
- 佩布罗利祖马布治疗导致温暖AIHA的发展.
- 在用类固醇治疗解决AIHA后,成功地重新使用达尔利马布.
主要成果:
- 佩姆布利祖马布诱导的温暖AIHA通过皮质类固醇治疗得到缓解.
- 使用德托拉利马布的挑战是可行的,并显示出有前途的结果.
- 患者可以接受替代ICI,但AIHA没有复发.
结论:
- 对于一些先前有过严重的IRA患者来说,使用替代性ICI可能是可行的选择.
- 仔细考虑irAE类型,严重程度和临床背景对于重新挑战的决定至关重要.
- 这一案例突显出一种潜在的策略,即尽管发生了IRA,但仍能保持癌症治疗的有效性.
更多相关视频
相关概念视频
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Immunodeficiency Diseases
3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
3.7K
Autoimmune Disorders
2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
